Better Stock to Buy: Newsmax vs. The New York Times
Newsmax (NMAX -1.68%) and The New York Times Company (NYT -1.05%) represent two opposite ends of the political spectrum in the media, and they're also two of the few pure-play news media stocks ava...
AM Best Revises Outlooks to Positive for Genworth Financial Group's Members; Affirms Credit Ratings of Genworth Financial, Inc. and Genworth Life a...
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating (FSR) of C++ (Marginal) and the Long-Term Issuer Cre...
How NYT's Digital Subscriptions Are Changing Revenue Dynamics
NYT's 11.3M digital subscribers, rising ARPU and strong Q3 guidance highlight its digital-first revenue momentum.
Titan Mining Announces Commissioning Readiness of U.S. Graphite Facility With Support From Federal and State Leaders
New York project marks a pivotal step toward U.S. graphite independence and the first integrated domestic supply chain in more than 70 years New York project marks a pivotal step toward U.S. graphi...
Trump to sue New York Times for $15 billion, alleging defamation and libel
Trump to sue New York Times for $15 billion, alleging defamation and libel
Trump sues New York Times
Donald Trump has announced he's suing The New York Times, just days after he threatened to do so over its reporting into his ties to Jeffrey Epstein.
OHA Announces Final Close of $1.1 Billion CLO Equity Fund OHA CLO Enhanced Equity Fund III
New York, New York, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”), a leading global credit-focused alternative asset manager, announced the final close of the third vintage of its CL...
OS Therapies to Participate in Upcoming Investor Conferences in September 2025
New York, New York--(Newsfile Corp. - September 3, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjuga...
OS Therapies Completes Exercise Inducement and Exchange Offer for All Remaining Outstanding Warrants Issued in Connection with December 2024 Financing
All remaining holders of outstanding warrants with $1.12 per share exercise price have participated, raising $3.7 million in gross proceeds to be used to accelerate OST-HER2 commercial launch prepa...
Surging Earnings Estimates Signal Upside for New York Times (NYT) Stock
New York Times Co. (NYT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why New York Times Co. (NYT) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The New York Times Company (NYT) Hit a 52 Week High, Can the Run Continue?
New York Times (NYT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The New York Times Company (NYT) Q2 2025 Earnings Call Transcript
The New York Times Company (NYSE:NYT ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Anthony Joseph DiClemente - Senior Vice President of Investor Relations Meredi...
New York Times Subscription, Ad Revenue Continue to Grow
The publisher ended the second quarter with 11.3 million digital-only subscribers and forecast further revenue gains.
Russia collusion 'lie': How CNN & New York Times played a starring role
Campus Reform reporter Emily Sturge and FOX Business' Cheryl Casone discuss the media's role in the Russia collusion lie on 'Mornings with Maria.' #foxbusiness #morningswithmaria
Related Companies